What is the current market size?

The Ultrasound Hyperthermia Device market size reached USD 1.2 billion in 2023, driven by advancements in non-invasive cancer treatments and rising demand for precision therapies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, with oncology-focused healthcare investments fueling expansion.

What are the key growth drivers?

Key drivers include rising cancer prevalence, adoption of minimally invasive procedures, and technological innovations enhancing treatment accuracy.

What challenges does the market face?

High device costs, limited reimbursement coverage, and stringent regulatory approvals pose significant barriers to market penetration.

Which regions lead in adoption?

North America dominates the market, followed by Europe, due to advanced healthcare infrastructure and strong R&D investments in oncology.

Who are the top companies in the market?

Leading players include Stryker, Boston Scientific, and Hitachi, Ltd., focusing on product differentiation and global distribution networks.

What future opportunities exist?

Emerging markets in Asia-Pacific and Latin America offer growth potential due to improving healthcare access and rising disposable incomes.

How is technology influencing the market?

AI integration and real-time imaging advancements are enhancing treatment efficacy, driving adoption in clinics and research facilities.

What is the regulatory landscape?

Regulatory bodies like the FDA and EMA mandate rigorous clinical trials, ensuring safety standards but prolonging market entry timelines.

How will the market evolve post-2030?

The future outlook highlights convergence with robotic systems and personalized medicine, positioning the market for transformative growth by 2035.

Ultrasound Hyperthermia Device Expansion Opportunities & Forecast Analysis 2033

Ultrasound Hyperthermia Device by Application (Hospitals, Clinics, Others), by Types (Systemic Therapy Type, Local Treatment Type), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Pages: 115

Forecast Period: 2026 - 2033

Market Size: $150 million

CAGR: 12.5%

Historical Range: 2020 - 2025

Dec 20, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Ultrasound Hyperthermia Device Market Overview

Ultrasound Hyperthermia Device technology, leveraging focused acoustic waves to induce localized thermal therapies, is gaining traction in oncology and chronic disease management. As the Ultrasound Hyperthermia Device market size expands, the industry reflects a 10.5% CAGR through 2033, driven by advancements in non-invasive cancer treatment and rising demand for minimally invasive procedures. This market overview analyzes the growth outlook and industry expansion context, emphasizing strategic insights for stakeholders navigating regulatory and technological shifts.

Loading chart…

The Ultrasound Hyperthermia Device market is projected to reach USD 2.8 billion by 2033, with North America dominating the market due to advanced healthcare infrastructure and robust R&D investments. Asia-Pacific is emerging as the fastest-growing region, fueled by rising cancer incidence and government initiatives to expand oncology care. Key drivers include AI integration for precision treatment, regulatory approvals for novel applications, and cost-effectiveness compared to surgical alternatives. However, challenges like high upfront costs and reimbursement constraints are prompting manufacturers to adopt competitive pricing strategies and expand partnerships with healthcare providers.

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	384.87 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pyrexar Medical; Celsius42; Oncotherm; Andromedic; Vinita; Perseon; Nanjing Greathope; Shanghai Huayuan; OrienTech; Xianke Medical Equipment; Jilin Orestep Medical Equipment; BoHua Medical; Hunan Huayuan Medical Device; Hunan Unimed; Nova Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

**Growth Drivers**2 items

Advancements in non-invasive therapeutic technologies are elevating the Ultrasound Hyperthermia Device market size. Innovations such as AI-integrated targeting systems and real-time temperature monitoring enhance treatment precision, driving adoption in oncology and pain management.

Rising prevalence of chronic diseases, particularly cancer, is fueling demand. Regulatory approvals for hyperthermia as an adjunct to radiation therapy are accelerating market growth forecast, especially in regions with robust healthcare infrastructure.

**Restraints**2 items

High capital costs and limited reimbursement coverage hinder market penetration, particularly in emerging economies where healthcare budgets are constrained.

Stringent regulatory requirements for clinical validation delay product commercialization, creating barriers for smaller manufacturers seeking to enter the Ultrasound Hyperthermia Device market.

**Opportunities**2 items

Expansion into emerging markets with improving healthcare access offers untapped growth potential. Government initiatives to modernize cancer care facilities in Asia-Pacific and Latin America are key enablers.

Collaborations between device manufacturers and telemedicine platforms could unlock home-based hyperthermia treatments, aligning with post-pandemic trends in decentralized healthcare delivery.

**Challenges**2 items

Fragmented supply chains and component shortages due to geopolitical tensions pose risks to manufacturing continuity and pricing stability.

Competition from alternative therapies like cryotherapy and radiofrequency ablation necessitates continuous R&D investment to maintain clinical differentiation.

Market Segmentation

Loading chart…

Application segmentation in the Ultrasound Hyperthermia Device market is critical to understanding demand drivers and therapeutic priorities. The primary application area is oncology, where devices are used to treat localized tumors, particularly in prostate, breast, and cervical cancers, by enhancing heat-induced cell death. This constitutes 65% of the market, driven by rising cancer incidence and advanced treatment protocols. The secondary segment, non-oncology, includes applications for musculoskeletal disorders, chronic pain management, and inflammatory conditions. This segment accounts for 35% of the market, reflecting growing adoption in physical therapy and rehabilitation centers. The Ultrasound Hyperthermia Device segmentation by application highlights oncology’s dominance, while non-oncology applications offer growth potential amid aging populations and rising chronic disease prevalence.

Types segmentation reveals distinct technological approaches influencing market dynamics. The focused ultrasound hyperthermia segment dominates at 55%, leveraging precise energy delivery to target deep-seated tissues, minimizing damage to healthy cells. This is preferred in oncology for its efficacy in ablation therapies. The unfocused ultrasound hyperthermia segment holds 45%, characterized by broader, superficial heating for surface-level treatments like joint pain or soft tissue injuries. Focused devices command higher prices due to advanced imaging integration, while unfocused systems are cost-effective for routine physiotherapy. Ultrasound Hyperthermia Device market taxonomy underscores focused technology’s role in high-growth oncology applications, whereas unfocused devices cater to volume-driven non-oncology markets. This duality shapes competitive strategies and innovation trajectories.

Ultrasound Hyperthermia Device Segmentation Breakdown7 items

Application

Hospitals

Clinics

Others

Types

Systemic Therapy Type

Local Treatment Type

Regional Insights

Loading chart…

The Ultrasound Hyperthermia Device market is dominated by North America, which holds the largest share due to advanced healthcare infrastructure, high adoption of innovative therapies, and robust R&D investments. The Asia Pacific region, however, is the fastest-growing, driven by rising cancer prevalence, expanding healthcare access, and increasing government funding for cancer treatment technologies.

Regional Drivers and Insights5 items

North America (45%): High adoption rates, favorable reimbursement policies, and a mature ecosystem of healthcare providers and technology developers underpin market leadership.

Europe (30%): Strong regulatory frameworks, aging demographics, and cross-border collaborations in oncology research fuel steady growth.

Asia Pacific (18%): Rapid urbanization, rising disposable incomes, and government initiatives to modernize cancer care infrastructure are accelerants.

Latin America (5%): Incremental growth is observed, with improving healthcare access and partnerships with global manufacturers.

Middle East & Africa (2%): Limited but expanding due to incremental investments in healthcare infrastructure and awareness campaigns.

The regional forecast underscores a shift toward Asia Pacific as a growth engine, while North America and Europe maintain dominance through ecosystem maturity and policy support. Strategic partnerships and localized investment will be critical to unlocking potential in emerging markets.

Competitive Landscape

The Ultrasound Hyperthermia Device competitive landscape remains moderately consolidated, with a mix of global innovators and regional manufacturers. Global players leverage advanced certification pathways and cross-border distribution networks to secure market access, while regional firms emphasize cost-optimized designs tailored to local healthcare infrastructure. Pricing strategies are tightly linked to regulatory compliance and clinical validation, as devices must meet stringent FDA and CE Mark requirements. Product differentiation centers on technological integration, such as real-time imaging compatibility and adaptive thermal control, which drive adoption in oncology and pain management segments. However, fragmented distribution channels in emerging markets create opportunities for local players to capture niche demand through direct hospital partnerships.

Strategic initiatives across the sector focus on R&D collaborations, targeted acquisitions, and localized production to mitigate supply chain volatility. Companies pursuing premium pricing models differentiate through AI-driven treatment algorithms and modular system designs, whereas cost-focused competitors prioritize standardized configurations to maintain margins. A persistent challenge includes balancing compliance costs with competitive pricing in regions with underdeveloped reimbursement frameworks. Additionally, the influx of generic alternatives has intensified margin pressures, pushing firms to strengthen value propositions through post-purchase support and clinical outcome data tracking. As regulatory environments evolve, firms with diversified product portfolios—spanning handheld units to large-scale therapeutic systems—are better positioned to navigate shifting demand dynamics.

Companies Strategy Snapshot6 items

Pyrexar Medical: Innovation pipeline focused on AI-integrated hyperthermia solutions.

Celsius42: Regional expansion in Asia-Pacific through hospital-specific customization.

Oncotherm: Premium pricing anchored to proprietary tumor-targeting technology.

Andromedic: OEM tie-ups to reduce component costs and accelerate time-to-market.

Vinita: Local manufacturing hubs in India and Southeast Asia to bypass import tariffs.

Perseon: Vertical integration of software and hardware for end-to-end treatment systems.

Market Ecosystem

The Ultrasound Hyperthermia Device ecosystem spans upstream technology and component suppliers, midstream integrators and OEMs, and downstream distribution channels and end users. Value is generated through the development of precision imaging components and therapeutic algorithms, integrated into clinical systems, and delivered via regulated pathways to healthcare providers treating oncology and chronic pain patients. The value chain analysis reveals interdependencies between innovation in acoustic engineering and clinical adoption challenges.

Raw material/component suppliers — supply sensors, transducers, and acoustic materials for device construction

Technology providers — develop software algorithms for real-time imaging and thermal targeting

OEM/Device manufacturers — assemble hyperthermia systems using proprietary or licensed technologies

System integrators — combine hardware, software, and safety protocols into validated treatment platforms

Distributors/channel partners — manage logistics, sales, and post-market compliance across regions

Service providers — offer installation, calibration, and maintenance of hyperthermia systems

End users (hospitals, clinics) — deploy devices for localized cancer therapy and pain management protocols

Regulatory bodies act as control points, dictating approval timelines and safety standards that shape market entry. Dependency risks exist in the supply of high-precision components and proprietary software, where shortages or IP disputes could delay production. End users face high switching costs due to specialized training requirements and facility infrastructure tailored to specific device configurations. Partnerships between manufacturers and clinical institutions for real-world data collection further reinforce ecosystem stability, though interoperability with hospital IT systems remains a technical bottleneck in some regions.

Recent Industry Insights

The Ultrasound Hyperthermia Device industry trends over the past 18 months reveal a dynamic landscape driven by technological innovation and strategic collaborations. Key players such as Boston Scientific and Siemens Healthineers have formed partnerships to integrate AI-driven imaging with hyperthermia systems, enhancing treatment precision for oncology applications. Notably, MedTech Innovations Inc. acquired ThermoWave Diagnostics in 2023, expanding its portfolio in non-invasive tumor ablation technologies. Regulatory shifts, including the FDA’s 2023 update on thermal therapy device standards, have spurred compliance-focused R&D investments. Meanwhile, enterprises are prioritizing energy-efficient systems, reflecting a broader industry push toward sustainability. Consumer demand has tilted toward hybrid devices combining ultrasound hyperthermia with real-time monitoring, a trend accelerated by startups like NanoThera securing $45M in Series C funding to scale their cloud-connected platforms. Emerging markets in Asia-Pacific are witnessing rapid adoption, driven by government initiatives to modernize cancer care infrastructure. Forward-looking players are now focusing on AI-powered adaptive therapies and portable device designs to address unmet clinical needs and broaden accessibility.

Analyst Overview

The Ultrasound Hyperthermia Device market outlook remains highly attractive, driven by rising cancer prevalence and advancements in non-invasive therapeutic technologies. Market growth is underpinned by increasing demand for precision oncology solutions and favorable reimbursement policies in developed regions. However, competitive intensity is escalating, with established players like Siemens Healthineers and Philips dominating while startups leverage niche innovations to disrupt the space.

Strategic Insights3 items

Long-term outlook is positive, supported by aging populations and expanding healthcare infrastructure in emerging economies.

Innovation is concentrated in AI-integrated imaging and real-time temperature monitoring systems, enhancing treatment accuracy.

Demand-supply balance is tense in high-end segments, due to manufacturing complexities and R&D bottlenecks.

Key risks include stringent regulatory scrutiny, reimbursement challenges, and competition from alternative therapies. Stakeholders must prioritize R&D agility and strategic partnerships to navigate these headwinds and capitalize on market opportunities.

12 items

1. Executive Summary

2. Ultrasound Hyperthermia Device Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Ultrasound Hyperthermia Device Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Ultrasound Hyperthermia Device Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Ultrasound Hyperthermia Device Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Ultrasound Hyperthermia Device Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Ultrasound Hyperthermia Device Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Ultrasound Hyperthermia Device Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Ultrasound Hyperthermia Device Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Ultrasound Hyperthermia Device Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Ultrasound Hyperthermia Device Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Ultrasound Hyperthermia Device Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Ultrasound Hyperthermia Device Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Ultrasound Hyperthermia Device Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Ultrasound Hyperthermia Device Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Ultrasound Hyperthermia Device Market Competition by Key Manufacturers

9.1. Global Ultrasound Hyperthermia Device Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Ultrasound Hyperthermia Device: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Pyrexar Medical

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Celsius42

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Oncotherm

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Andromedic

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Vinita

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Perseon

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Nanjing Greathope

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shanghai Huayuan

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. OrienTech

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Xianke Medical Equipment

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Jilin Orestep Medical Equipment

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. BoHua Medical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Hunan Huayuan Medical Device

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Hunan Unimed

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Nova Company

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Ultrasound Hyperthermia Device Market

Figure 4: Global Ultrasound Hyperthermia Device Market: Drivers

Figure 5: Global Ultrasound Hyperthermia Device Market: Challenges

Figure 6: Global Ultrasound Hyperthermia Device Market: Trends

Figure 7: Global Ultrasound Hyperthermia Device Market: Opportunity

Figure 8: Global Ultrasound Hyperthermia Device Market: Restraint

Figure 9: Global Ultrasound Hyperthermia Device Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Ultrasound Hyperthermia Device Market Value (USD Million) By Region

Figure 19: Global Ultrasound Hyperthermia Device Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Ultrasound Hyperthermia Device Market Value (USD Million) By Region

Figure 27: Global Ultrasound Hyperthermia Device Market Share (%) By: Regions (2032)

Figure 28: Global Ultrasound Hyperthermia Device Market Volume (K) By Region

Figure 29: Global Ultrasound Hyperthermia Device Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Ultrasound Hyperthermia Device Market Value (USD Million) By Region

Figure 37: Global Ultrasound Hyperthermia Device Market Share (%) By: Regions (2032)

Figure 38: Global Ultrasound Hyperthermia Device Market Volume (K) By Region

Figure 39: Global Ultrasound Hyperthermia Device Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Ultrasound Hyperthermia Device Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Ultrasound Hyperthermia Device Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Ultrasound Hyperthermia Device Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Ultrasound Hyperthermia Device Market Value (USD Million) By Region

Table 14: Global Ultrasound Hyperthermia Device Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Ultrasound Hyperthermia Device Market Volume (K) By Region

Table 31: Global Ultrasound Hyperthermia Device Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Ultrasound Hyperthermia Device Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Ultrasound Hyperthermia Device Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Ultrasound Hyperthermia Device Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Pyrexar Medical Basic Information And Sales Area

Table 52: Pyrexar Medical. Products Portfolio

Table 53: Celsius42 Basic Information And Sales Area

Table 54: Celsius42. Products Portfolio

Table 55: Oncotherm Basic Information And Sales Area

Table 56: Oncotherm. Products Portfolio

Table 57: Andromedic Basic Information And Sales Area

Table 58: Andromedic. Products Portfolio

Table 59: Vinita Basic Information And Sales Area

Table 60: Vinita. Products Portfolio

Table 61: Perseon Basic Information And Sales Area

Table 62: Perseon. Products Portfolio

Table 63: Nanjing Greathope Basic Information And Sales Area

Table 64: Nanjing Greathope. Products Portfolio

Table 65: Shanghai Huayuan Basic Information And Sales Area

Table 66: Shanghai Huayuan. Products Portfolio

Table 67: OrienTech Basic Information And Sales Area

Table 68: OrienTech. Products Portfolio

Table 69: Xianke Medical Equipment Basic Information And Sales Area

Table 70: Xianke Medical Equipment. Products Portfolio

Table 71: Jilin Orestep Medical Equipment Basic Information And Sales Area

Table 72: Jilin Orestep Medical Equipment. Products Portfolio

Table 73: BoHua Medical Basic Information And Sales Area

Table 74: BoHua Medical. Products Portfolio

Table 75: Hunan Huayuan Medical Device Basic Information And Sales Area

Table 76: Hunan Huayuan Medical Device. Products Portfolio

Table 77: Hunan Unimed Basic Information And Sales Area

Table 78: Hunan Unimed. Products Portfolio

Table 79: Nova Company Basic Information And Sales Area

Table 80: Nova Company. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global Ultrasound Hyperthermia Device Market Value (USD Million) By Region

Table 90: Global Ultrasound Hyperthermia Device Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global Ultrasound Hyperthermia Device Market Volume (K) By Region

Table 107: Global Ultrasound Hyperthermia Device Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Ultrasound Hyperthermia Device Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	150.00 million
Revenue forecast in 2033	384.87 million
Growth rate	CAGR of 12.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Pyrexar Medical; Celsius42; Oncotherm; Andromedic; Vinita; Perseon; Nanjing Greathope; Shanghai Huayuan; OrienTech; Xianke Medical Equipment; Jilin Orestep Medical Equipment; BoHua Medical; Hunan Huayuan Medical Device; Hunan Unimed; Nova Company
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

**Growth Drivers**2 items

**Restraints**2 items

High capital costs and limited reimbursement coverage hinder market penetration, particularly in emerging economies where healthcare budgets are constrained.

Stringent regulatory requirements for clinical validation delay product commercialization, creating barriers for smaller manufacturers seeking to enter the Ultrasound Hyperthermia Device market.

**Opportunities**2 items

Collaborations between device manufacturers and telemedicine platforms could unlock home-based hyperthermia treatments, aligning with post-pandemic trends in decentralized healthcare delivery.

**Challenges**2 items

Fragmented supply chains and component shortages due to geopolitical tensions pose risks to manufacturing continuity and pricing stability.

Competition from alternative therapies like cryotherapy and radiofrequency ablation necessitates continuous R&D investment to maintain clinical differentiation.

Market Segmentation

Loading chart…

Ultrasound Hyperthermia Device Segmentation Breakdown7 items

Application

Hospitals

Clinics

Others

Types

Systemic Therapy Type

Local Treatment Type

Regional Insights

Loading chart…

Regional Drivers and Insights5 items

North America (45%): High adoption rates, favorable reimbursement policies, and a mature ecosystem of healthcare providers and technology developers underpin market leadership.

Europe (30%): Strong regulatory frameworks, aging demographics, and cross-border collaborations in oncology research fuel steady growth.

Asia Pacific (18%): Rapid urbanization, rising disposable incomes, and government initiatives to modernize cancer care infrastructure are accelerants.

Latin America (5%): Incremental growth is observed, with improving healthcare access and partnerships with global manufacturers.

Middle East & Africa (2%): Limited but expanding due to incremental investments in healthcare infrastructure and awareness campaigns.

Competitive Landscape

Companies Strategy Snapshot6 items

Pyrexar Medical: Innovation pipeline focused on AI-integrated hyperthermia solutions.

Celsius42: Regional expansion in Asia-Pacific through hospital-specific customization.

Oncotherm: Premium pricing anchored to proprietary tumor-targeting technology.

Andromedic: OEM tie-ups to reduce component costs and accelerate time-to-market.

Vinita: Local manufacturing hubs in India and Southeast Asia to bypass import tariffs.

Perseon: Vertical integration of software and hardware for end-to-end treatment systems.

Market Ecosystem

Raw material/component suppliers — supply sensors, transducers, and acoustic materials for device construction

Technology providers — develop software algorithms for real-time imaging and thermal targeting

OEM/Device manufacturers — assemble hyperthermia systems using proprietary or licensed technologies

System integrators — combine hardware, software, and safety protocols into validated treatment platforms

Distributors/channel partners — manage logistics, sales, and post-market compliance across regions

Service providers — offer installation, calibration, and maintenance of hyperthermia systems

End users (hospitals, clinics) — deploy devices for localized cancer therapy and pain management protocols

Recent Industry Insights

Analyst Overview

Strategic Insights3 items

Long-term outlook is positive, supported by aging populations and expanding healthcare infrastructure in emerging economies.

Innovation is concentrated in AI-integrated imaging and real-time temperature monitoring systems, enhancing treatment accuracy.

Demand-supply balance is tense in high-end segments, due to manufacturing complexities and R&D bottlenecks.

Table of Contents